Clinical Trials Browser

NETWORK × Nivolumab × Gastrointestinal × Clear all

NCT03443856 2024-01-05

VESTIGE

Phase 2 Active not recruiting

Gastrointestinal

Gastric and Esophagogastric Junction Adenocarcinoma

NCT03647839 2021-08-27

MODULATE

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms